Your session is about to expire
← Back to Search
Low Dose Aspirin for Preeclampsia
Study Summary
This trial seeks to determine whether taking low dose aspirin (LDA) can reduce long-term risk of cardiovascular disease in women who had preeclampsia during pregnancy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I used low-dose aspirin during a normal pregnancy.I have a liver, metabolic condition, or kidney disease with reduced kidney function.I take aspirin every day.I have a skin condition.I am taking medication to lower my cholesterol.I had preeclampsia and did not take low-dose aspirin during my pregnancy.I am currently taking medication for high blood pressure.I am 18 years old or older.I had preeclampsia and took low-dose aspirin during my pregnancy.I had a normal pregnancy without taking low dose aspirin.
- Group 1: assessment of microvascular function
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it permissible to join this investigation if one is of an advanced age?
"The eligibility criteria for this research mandates that patients must be between 18 years and 50 years of age."
Is enrollment in this research endeavor still available?
"The current status of this medical trial, which was initially listed on March 1st 2023, is actively recruiting. As per the latest update from April 24th 2023, it can be found on clinicaltrials.gov."
How many participants is this study enrolling at present?
"Affirmative. According to the information located on clinicaltrials.gov, this study has been recruiting participants since its initial post date of March 1st 2023 and is currently seeking 60 people from one site."
Would I meet the criteria to take part in this investigation?
"This clinical trial is enrolling sixty persons aged 18 to 50 with a prior history of preeclampsia. In addition, individuals must meet the following criteria: being eighteen years or older; having had a normal gestation and abstaining from taking low-dose aspirin (LDA) during pregnancy; experiencing skin diseases; using tobacco products; suffering from hepatic or metabolic disorders such as chronic kidney disease (CKD), characterized by an eGFR lower than 60 mL/min/1.73m2s; and currently engaging in daily intake of aspirin within 12 weeks up to five years after delivering their baby."
Share this study with friends
Copy Link
Messenger